Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5668.5000 25.00 (0.44%)

NSE Nov 07, 2025 15:31 PM

Near 52W High of ₹5786.90

Volume: 226.7K

Alkem Laboratories Ltd.

14 Nov 2022

5668.50

0.44%

Alkem Labs (SELL): Near-term outlook weak cut to SELL

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Revenue grew 10% YoY to Rs 31bn in Q2 led by India business, but US price erosion continued to weigh on margins

Alkem Laboratories L.. has an average target of 5463.50 from 2 brokers.